NO895158L - Fremgangsmaate for fremstilling av antiretrovirale furanketoner. - Google Patents
Fremgangsmaate for fremstilling av antiretrovirale furanketoner.Info
- Publication number
- NO895158L NO895158L NO89895158A NO895158A NO895158L NO 895158 L NO895158 L NO 895158L NO 89895158 A NO89895158 A NO 89895158A NO 895158 A NO895158 A NO 895158A NO 895158 L NO895158 L NO 895158L
- Authority
- NO
- Norway
- Prior art keywords
- forconsets
- antiretroviral
- procedure
- manufacturing
- antiretroviral forconsets
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/58—One oxygen atom, e.g. butenolide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/64—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28776288A | 1988-12-21 | 1988-12-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO895158D0 NO895158D0 (no) | 1989-12-20 |
| NO895158L true NO895158L (no) | 1990-06-22 |
Family
ID=23104228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO89895158A NO895158L (no) | 1988-12-21 | 1989-12-20 | Fremgangsmaate for fremstilling av antiretrovirale furanketoner. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0374886A3 (ko) |
| JP (1) | JPH02221269A (ko) |
| KR (1) | KR900009620A (ko) |
| CN (1) | CN1043711A (ko) |
| AU (1) | AU621434B2 (ko) |
| CA (1) | CA2005991A1 (ko) |
| DK (1) | DK650089A (ko) |
| FI (1) | FI896134A0 (ko) |
| HU (1) | HUT52492A (ko) |
| IL (1) | IL92796A0 (ko) |
| NO (1) | NO895158L (ko) |
| NZ (1) | NZ231856A (ko) |
| PH (1) | PH26687A (ko) |
| PT (1) | PT92633A (ko) |
| ZA (1) | ZA899742B (ko) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA899743B (en) * | 1988-12-21 | 1990-09-26 | Merrell Dow Pharma | Antiretroviral aryloxy substituted furan ketones |
| US5665874A (en) * | 1989-01-17 | 1997-09-09 | John Hopkins University | Cancer related antigen |
| US5759837A (en) * | 1989-01-17 | 1998-06-02 | John Hopkins University | Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway |
| US5759791A (en) * | 1989-01-17 | 1998-06-02 | The Johns Hopkins University | Cancer related antigen |
| US5614551A (en) * | 1994-01-24 | 1997-03-25 | The Johns Hopkins University | Inhibitors of fatty acid synthesis as antimicrobial agents |
| US5981575A (en) * | 1996-11-15 | 1999-11-09 | Johns Hopkins University, The | Inhibition of fatty acid synthase as a means to reduce adipocyte mass |
| CN100395241C (zh) * | 2006-05-26 | 2008-06-18 | 中国科学院南海海洋研究所 | 一种降解呋喃二倍半萜角质海绵素及其制备方法和应用 |
| CN101820757A (zh) | 2007-06-01 | 2010-09-01 | 普林斯顿大学托管委员会 | 通过调节宿主细胞代谢途径治疗病毒感染 |
| ES2481346B1 (es) * | 2012-12-26 | 2015-05-08 | Consejo Superior De Investigaciones Científicas (Csic) | Procedimiento de obtención de moléculas orgánicas útiles como nuevos agentes surfactantes. |
| CN114163407B (zh) * | 2020-09-11 | 2023-10-24 | 中国科学院宁波材料技术与工程研究所 | 抑制或杀灭微生物的呋喃环类成分、含其的制品及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1104574A (en) * | 1976-12-20 | 1981-07-07 | Roger A. Parker | Antirhinovirus agents |
| FR2518999A1 (fr) * | 1981-12-28 | 1983-07-01 | Agrifurane Sa | Procede de preparation de composes cetoniques en particulier de composes furanniques ou composes cetoniques a longues chaines, composes furanniques et composes cetoniques a longues chaines prepares par mise en oeuvre dudit procede |
| US4801698A (en) * | 1986-08-15 | 1989-01-31 | Warner-Lambert Company | Process for preparing diaminopyrimido(4,5-d)pyrimidine glycoside and glycotide |
| ZA899743B (en) * | 1988-12-21 | 1990-09-26 | Merrell Dow Pharma | Antiretroviral aryloxy substituted furan ketones |
-
1989
- 1989-12-18 AU AU46930/89A patent/AU621434B2/en not_active Ceased
- 1989-12-19 NZ NZ231856A patent/NZ231856A/en unknown
- 1989-12-19 CA CA002005991A patent/CA2005991A1/en not_active Abandoned
- 1989-12-19 IL IL92796A patent/IL92796A0/xx unknown
- 1989-12-19 ZA ZA899742A patent/ZA899742B/xx unknown
- 1989-12-20 KR KR1019890019004A patent/KR900009620A/ko not_active Application Discontinuation
- 1989-12-20 EP EP19890123559 patent/EP0374886A3/en not_active Ceased
- 1989-12-20 JP JP1330945A patent/JPH02221269A/ja active Pending
- 1989-12-20 HU HU896706A patent/HUT52492A/hu unknown
- 1989-12-20 NO NO89895158A patent/NO895158L/no unknown
- 1989-12-20 DK DK650089A patent/DK650089A/da not_active Application Discontinuation
- 1989-12-20 FI FI896134A patent/FI896134A0/fi not_active Application Discontinuation
- 1989-12-20 PT PT92633A patent/PT92633A/pt not_active Application Discontinuation
- 1989-12-21 CN CN89109422A patent/CN1043711A/zh active Pending
- 1989-12-21 PH PH39761A patent/PH26687A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PH26687A (en) | 1992-09-15 |
| CA2005991A1 (en) | 1990-06-21 |
| FI896134A0 (fi) | 1989-12-20 |
| DK650089A (da) | 1990-06-22 |
| HU896706D0 (en) | 1990-02-28 |
| KR900009620A (ko) | 1990-07-05 |
| AU621434B2 (en) | 1992-03-12 |
| EP0374886A2 (en) | 1990-06-27 |
| NZ231856A (en) | 1991-05-28 |
| CN1043711A (zh) | 1990-07-11 |
| PT92633A (pt) | 1990-06-29 |
| DK650089D0 (da) | 1989-12-20 |
| NO895158D0 (no) | 1989-12-20 |
| ZA899742B (en) | 1990-09-26 |
| HUT52492A (en) | 1990-07-28 |
| JPH02221269A (ja) | 1990-09-04 |
| IL92796A0 (en) | 1990-09-17 |
| AU4693089A (en) | 1990-06-28 |
| EP0374886A3 (en) | 1992-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO885605L (no) | Fremgangsmaate for fremstilling av smoereolje. | |
| NO885359L (no) | Fremgangsmaate for fremstilling av sprengstoff. | |
| NO885454D0 (no) | Fremgangsmaate for fremstilling av triklormonosilan. | |
| NO882295D0 (no) | Fremgangsmaate for fremstilling av paryledimeren. | |
| NO892068D0 (no) | Fremgangsmaate ved fremstilling av naftatiozepinoner. | |
| NO894210D0 (no) | Fremgangsmaate for fremstilling av kinolyloxazol-2-oner. | |
| NO894649D0 (no) | Fremgangsmaate for fremstilling av (s)-alfa-ethyl-2-oxo-1-pyrrolidinacetamid. | |
| NO890483D0 (no) | Framgangsmaate for tilvirkning av formlegemer. | |
| NO895032L (no) | Fremgangsmaate for fremstilling av 2-benzotiazoliner. | |
| NO892561D0 (no) | Fremgangsmaate for fremstilling av bindemidler. | |
| NO895158L (no) | Fremgangsmaate for fremstilling av antiretrovirale furanketoner. | |
| NO881834L (no) | Fremgangsmaate for fremstilling av hydrokarboner. | |
| NO890159D0 (no) | Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler. | |
| NO885200L (no) | Fremgangsmaate for fremstilling av pro-legemidler. | |
| NO893890L (no) | Fremgangsmaate for fjerning av sulfider. | |
| NO895040D0 (no) | Fremgangsmaate for fremstilling av polyhydroxybenzyloxypropanolaminer. | |
| NO870828D0 (no) | Fremgangsmaate for fremstilling av biskarbamater. | |
| NO900381D0 (no) | Fremgangsmaate for fremstilling av nafthalenderivater. | |
| NO891898D0 (no) | Fremgangsmaate ved fremstilling av naftotiazepinoner. | |
| FI892409A0 (fi) | Anordning foer bildning av uppaot staoende list. | |
| NO871721D0 (no) | Fremgangsmaate for fremstilling av ergolenderivater. | |
| NO893937D0 (no) | Fremgangsmaate for fremstilling av pizza. | |
| NO893936D0 (no) | Fremgangsmaate for fremstilling av pizza. | |
| NO875268L (no) | Fremgangsmaate for fremstilling av urea-formaldehydharpikser. | |
| NO894285D0 (no) | Framgangsmaate for framstilling av baatskrog. |